NUTRA PHARMA Reports Change in Control; Pure Raw Supplies Now Controlling

What Happened
NUTRA PHARMA CORP filed an 8‑K (dated Sept 2, 2026) reporting a change in control that occurred on August 21, 2026. On that date Rik Deitsch transferred 12,000,000 shares of the company’s Series B Preferred Stock to Pure Raw Supplies, LLC as a gift and for no consideration. Under the Series B Certificate of Designation, those shares carry supermajority voting rights; immediately after the transfer Pure Raw Supplies held 62.63% of the company’s total voting power and became the controlling stockholder.

Key Details

• Transfer date: August 21, 2026; 8‑K filed Sept 2, 2026.
• Shares transferred: 12,000,000 shares of Series B Preferred Stock.
• Voting power: Pure Raw Supplies now holds 62.63% of total voting power.
• Consideration: Transfer was a gift—no payment was made; prior voting power was held by Rik Deitsch.

Why It Matters
A change in control is a material governance event: the new controlling stockholder (Pure Raw Supplies) has voting power sufficient to determine the outcome of most matters submitted to shareholders (e.g., director elections, major corporate actions). Investors should note this shift in control and watch for related filings (changes to the board, management, or related-party transactions) that could affect company strategy, governance, or shareholder value.